Clinical Trials Logo

Deep Sedation clinical trials

View clinical trials related to Deep Sedation.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06165848 Completed - Deep Sedation Clinical Trials

Effects Of Different Anesthesia Applications On Mood, Depression, And Anxiety Levels In Burn Patients

Start date: July 9, 2020
Phase:
Study type: Observational [Patient Registry]

Adequate and effective pain management and prevention of depression are essential in burn patients. This study aims to investigate the effects of ketamine sedation in burn patients in terms of mood disorders, depression, anxiety, and suicidal tendency during intensive care follow-up in the postoperative period.

NCT ID: NCT05674201 Completed - Deep Sedation Clinical Trials

Effects Of Propofol-Dexmedetomıdıne And Propofol- Remıfentanıl In Hysteroscopıc Operations.

Start date: June 17, 2021
Phase:
Study type: Observational [Patient Registry]

In our study, the investigators aimed to compare the effects of dexmedetomidine-propofol and remifentanil-propofol combinations on perioperative spontaneous respiration, hemodynamics, recovery, participants, surgeon and anesthetist satisfaction in hysteroscopy, which is one of the ambulatory surgery.

NCT ID: NCT05587803 Completed - Deep Sedation Clinical Trials

Comparison of 2 Depth of Sedation Indices in the Intensive Care Unit

PSIWAV
Start date: May 9, 2022
Phase: N/A
Study type: Interventional

In the intensive care unit of the Free University hospital of Brussels, sedated patients are standardly monitored with the Masimo SEDline device to see how deeply a patient is asleep. During this study we want to attach 1 extra device to 30 sedated patients, lying in the intensive care unit. This device, called the NeuroSENSE brain monitor from Neurowave systems, uses a different scale to indicate the ideal depth of sedation. In total, both devices will be hung on a patient for 2 times 35 minutes. At minute 33, a RASS score will be determined in each patient. This score will be determined by talking to the patient or administering a pain stimulus. Based on the reaction of the patient an estimation can be made how deeply a patient is sleeping. Our goal is to find out which device correlates best with the effective clinical state of the patient.

NCT ID: NCT05163704 Completed - Deep Sedation Clinical Trials

Dexmedetomidine Sedation in Children Before MRI Examinations

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

Dexmedetomidine, has been used in the past 4-5 years as an alternative sedation method for children at the pediatric radiology department in order to reduce the waiting lists and the use of general anesthesia with its risks and side effects in magnetic resonance and computed tomography examinations.

NCT ID: NCT05091151 Completed - Anesthesia Clinical Trials

Intranasal Dexmedetomidine Sedation at Dose of 2 mcg/kg Versus 4 mcg/kg in Children Undergoing MRI

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

This study aimed to compare the effectiveness of intranasal Dexmedetomidine sedation at Dose of 2 mcg/kg and 4 mcg/kg in Children Undergoing MRI at Cipto Mangunkusumo Hospital

NCT ID: NCT04695509 Completed - Deep Sedation Clinical Trials

Sedation and Neuromediators Concentration

Start date: October 5, 2020
Phase: N/A
Study type: Interventional

Propofol (Propofol Kabi, Registration number from the State Register of Medicines - 000875) is a widely used intravenous anesthetic. It is well known about different effects of propofol infusion, including euphoria, psycholalia, disinhibition, talkativeness, satisfaction etc. However, the basic mechanisms of such effects remain unknown. We suppose that propofol sedation with various levels of sedation (from light to deep) leads to neuromediators changes. We examine dopamine, noradrenaline, acetylcholine, GABA and serotonin in peripheral venous blood before, during and after propofol sedation. Therefore, we suppose drugs for sedation, in particular, propofol will affect neuromediators concentration.

NCT ID: NCT04509414 Completed - Dexmedetomidine Clinical Trials

Intranasal Dexmedetomidine for Deep-sedated Pediatric Dental Patients

Start date: April 10, 2020
Phase: Phase 4
Study type: Interventional

It is important to choose an appropriate analgesia/sedation technique in pediatric dental treatment. Premedication combined with intravenous anesthesia is often used in deep sedation technique for pediatric dental treatment and it's a routine in most hospitals. Deep sedation has its unique advantages such as avoiding the airway damage with an enhanced recovery. Dexmedetomidine is suitable for intranasal mucosal administration as a premedication drug. It has been proved with several beneficial characteristics in other clinical procedures. This study intends to further explore the characteristics of nasal dexmedetomidine as premedication in pediatric oral treatment under deep sedation.

NCT ID: NCT04141267 Completed - Clinical trials for Endotracheal Intubation

Inhaled Sedation Using the Anesthetic-conserving Device ( ANACONDA) in Prehospital Emergency Medecine.

ANACONDA
Start date: May 3, 2019
Phase:
Study type: Observational

Achieving the optimal sedation level for patient management is not always possible using our standard intravenous medications in Pre-hospital Emergency medicine. Inhaled sedation is possible with the Anesthetic-conserving device with a standard respirator. The pharmacodynamics and pharmacokinetics of halogenated agents allow deep sedation quickly after absorption. The feasibility of inhaled sedation has never been studied in hospital.

NCT ID: NCT03652324 Completed - Deep Sedation Clinical Trials

What Should be the Anesthesia Method in Endobronchial Coil Treatment

Start date: March 28, 2018
Phase: N/A
Study type: Interventional

This prospective, randomize study was conducted in a university hospital. Bronchoscopic lung volume reduction (BLVR) coil treatment has recently been introduced into clinical practice as an alternative for patients chronic obstructive pulmonary disease (COPD) with severe refractory heterorogenous emphysema to conventional medical treatment. Thirty two patients diagnosed with (COPD) with severe refractory heterorogenous emphysema undergoing BLVR coil treatment were included in the study. Seventeen procedure were performed under general anesthesia and fifteen procedure were performed under deep sedation-analgesia. in the general anesthesia group peak pressure, air leakage and end-tidal carbon dioxide were recorded. In the both groups pulse oximeter, transcutaneous carbondioxide, recovery time, bronchospasm, laryngospasm, pneumothorax, massive bleeding were recorded.

NCT ID: NCT02983331 Completed - Mortality Clinical Trials

Mortality After Endoscopic Retrograde Cholangiopancreatography

Start date: April 2016
Phase: N/A
Study type: Observational

In this study, the investigators aimed to overview patients with specific and non-specific complications who admitted to intensive care unit following endoscopic retrograde cholangiopancreatography and had fatal course in the facility